The document discloses that pulse oximetry readings may be inaccurate due to the user's skin tone, physical characteristics, device fit, and ambient light, and states that pulse ox data is not intended for medical purposes or clinical use.
This analysis describes what Garmin's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
This provision explicitly acknowledges that skin tone is a variable that may affect pulse oximetry accuracy, which intersects with ongoing FDA regulatory scrutiny of consumer and clinical SpO2 devices regarding performance disparities across diverse skin tones. The disclosure that Garmin may release software updates to improve measurements indicates ongoing development but does not commit to a specific accuracy standard.
Under this clause, users with certain skin tones or physical characteristics are informed that pulse oximetry readings may be less accurate, and the data is stated to be unsuitable for medical decision-making. The agreement reserves the right to update device software to improve measurement quality without specifying a timeline or accuracy target.
Cross-platform context
See how other platforms handle Pulse Oximetry Accuracy Limitations and Skin Tone Disclosure and similar clauses.
Compare across platforms →"While every effort is made to ensure a high degree of accuracy, there are certain limitations that can cause inaccurate measurements. The user's skin tone and other physical characteristics, fit of the device, and presence of ambient light may impact the readings. Garmin may release device software over time to improve aspects of the measurements. The Pulse Ox data is not intended to be used for medical purposes, nor is it intended to diagnose, treat, cure or prevent any disease or condition.Excerpt from Garmin's Terms of Use
REGULATORY LANDSCAPE: The FDA has issued safety communications and guidance regarding pulse oximetry accuracy in consumer and clinical devices, specifically addressing performance disparities related to skin pigmentation.
Enforcement risk, jurisdiction flags, contract triggers, and due diligence action items.
Get the research letter
Companies change their terms quietly. We read every version and catch what actually changed. One email a week on the changes that matter and what they mean.
This provision explicitly acknowledges that skin tone is a variable that may affect pulse oximetry accuracy, which intersects with ongoing FDA regulatory scrutiny of consumer and clinical SpO2 devices regarding performance disparities across diverse skin tones. The disclosure that Garmin may release software updates to improve measurements indicates ongoing development but does not commit to a specific accuracy standard.
Under this clause, users with certain skin tones or physical characteristics are informed that pulse oximetry readings may be less accurate, and the data is stated to be unsuitable for medical decision-making. The agreement reserves the right to update device software to improve measurement quality without specifying a timeline or accuracy target.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by Garmin.